MGMT-methylated gliomas exhibited significantly higher ADCmin (0.86 vs. 0.74 × 10-3mm2/s, p = 0.013) and rADCmin (1.12 vs. 0.95, p<0.001). The gene discussed is MGMT; the disease is central nervous system cancer.